UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

___________________

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2006

Commission File Number 1-32654

___________________

ANORMED INC.

(Translation of registrant's name into English)

#200 – 20353 64^th Avenue

Langley, British Columbia

Canada V2Y 1N5

(Address of principal executive offices)

___________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [ ] Form 40-F [X]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) [ ]

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes [ ] No [X]

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- .

INCORPORATION BY REFERENCE

~~Exhibit~~Exhibits 99.1 to 99.4 to this Form 6-K shall be incorporated by reference into the Prospectus and Registration Statement on Form S-8 of AnorMED Inc. (File No. 333-135097).

DOCUMENTS FILED

See the Exhibit Index hereto for a list of the documents filed herewith and forming a part of this Form 6-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ANORMED INC.

By :

/s/ ~~Gary~~W. ~~Bridger~~J. Adams

Name: ~~Gary~~William ~~Bridger~~J. (Bill) Adams

Title:

Title: Chief ~~Scientific~~Financial Officer, Vice President, Finance, Secretary and Treasurer

~~Vice~~Date: August ~~President~~28, ~~Research & Development~~2006

Date: August 14, 2006

EXHIBIT INDEX

Exhibit	Description
32.1	CEO Certification
99.1	Notice of Meeting and Information Circular
32.2	CFO Certification
99.2	Form of Proxy
99.1	First Quarter Report
99.3	Financial Statement Request Form
99.4	Board Mandate
99.5	Code of Business Conduct and Ethics

Filing Compare · AnorMED Inc.